As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: February 19, 2017
by Health Day News:
There has been a sharp rise in the number of American seniors who take three or more medications that affect their brains, a new study reveals.
The study looked at seniors’ use of opioid painkillers, antidepressants, tranquilizers and antipsychotic drugs. A review of U.S. Centers for Disease Control and Prevention data showed that the use of these drugs in people over 65 more than doubled from 2004 to 2013.
The researchers estimated that approximately 3.7 million doctor visits a year are by seniors taking three or more of these drugs. The largest increase was seen among seniors in rural areas. There, the use of these drugs more than tripled.
The spike in the combined use of drugs that act on the central nervous system is cause for concern because it can lead to falls and resulting injuries, affect driving ability, and cause memory and thinking problems, the study authors noted.
Taking opioid painkillers (such as Oxycontin) along with certain other brain-affecting drugs — including benzodiazepine tranquilizers (such as Valium and Xanax) — is of particular concern due to the increased risk of death, the researchers explained.
“The rise we saw in these data may reflect the increased willingness of seniors to seek help and accept medication for mental health conditions — but it’s also concerning because of the risks of combining these medications,” said study lead author Dr. Donovan Maust. He is a geriatric psychiatrist at the University of Michigan’s academic medical center, in Ann Arbor.
Another worrisome finding was that nearly half of seniors taking these drug combinations didn’t have a formal diagnosis of a mental health condition, insomnia or pain condition — the three main types of problems the drugs are typically prescribed for.
“We hope that the newer prescribing guidelines for older adults encourage providers and patients to reconsider the potential risks and benefits from these combinations,” Maust said in a university news release.
Findings from the study were published Feb. 13 in the journal JAMA Internal Medicine.
White women whose genes put them at risk of developing Alzheimer’s disease are more likely than white men with similar risk genes to be diagnosed between the ages of 65 and 75, a study drawing on...
Researchers at the Keck School of Medicine of USC are tackling the sixth-leading cause of death in the United States—Alzheimer’s disease—with a new study that intervenes decades before the disease develops. The school is...
A devastating chronic neurodegenerative disease, Alzheimer’s disease (AD) currently affects around 5.5 million people in the United States alone. Causing progressive mental deterioration, it ultimately advances to impact basic bodily functions such as walking and...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.